Brian Matthew Bloom and Bloom Burton & Co. Inc. Acquire 7.35% Stake in Satellos Bioscience Inc.

Satellos Bioscience Inc. (the 'Issuer') has reported a new beneficial ownership position by a group of reporting persons including Brian Matthew Bloom, Bloom Burton & Co. Inc., and Jolyon David Burton. According to the Schedule 13G filing dated May 13, 2026, the reporting persons collectively hold 1,137,041 common shares, representing approximately 7.35% of the company's outstanding stock. The ownership structure includes 126,874 shares over which Brian Matthew Bloom holds sole voting and dispositive power, consisting of personal records, holdings via 2194655 Ontario Inc., and exercisable options. Additionally, 1,010,167 shares are held with shared power through Bloom Burton & Co. Inc. and Bloom Burton Development Corporation. Mr. Bloom and Mr. Burton jointly control Bloom Burton & Co. Inc., which in turn controls Bloom Burton Development Corporation. The calculation is based on 15,458,903 ordinary shares outstanding as of February 5, 2026. The filing was triggered by an event on February 6, 2026, establishing the group as significant shareholders in the clinical-stage biotechnology company.